Novel roles of HCMV-specific humoral immunity, NK cells, and γδ T cells after allogeneic stem cell transplantation in the Letermovir era (DGHO 2025) - Nov 6, 2025 - Abstract #P900; Pres time: Oct 26, 2025; 06:27 PM - 06:34 PM; Location: Congress Hall 3 (CC Ost); "As vaccine candidates progress in clinical trials, understanding the interplay between humoral and cellular immunity will be key to optimizing vaccination timing and guiding novel therapeutic strategies. Furthermore, early monitoring of humoral responses or γδ T-cell frequencies may enhance prognostic immune surveillance beyond conventional T-cell markers."
Bone Marrow Transplantation • Cytomegalovirus Infection • Hematological Malignancies • Infectious Disease • Leukemia • Transplantation
|
|
Lauruschkat C. 1; Görge H. 1; Knies K. 2; Weißbrich B. 2; Dölken L. 3; Köchel C. 1; Imhof N. 1; Huber M. 4; Hengel H. 4; Einsele H. 1,5; Wurster S. 6; Kraus S. 1
|